Elżbieta Szwench-Pietrasz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elżbieta Szwench-Pietrasz has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Agata Kubik
Magnetic Resonance Unit, National Institute of Cardiology, 04-628 Warsaw, Poland
1 shared publication - Agnieszka Łebek-Szatańska
Department of Hypertension, Cardinal Stefan Wyszynski Institute of Cardiology in Warsaw, Alpejska 42 Street, 04-628 Warsaw, Poland
1 shared publication - Andrzej Januszewicz
Department of Hypertension, National Institute of Cardiology, Warsaw, Poland
1 shared publication - Elżbieta Florczak
Department of Hypertension, National Institute of Cardiology, 04-628 Warsaw, Poland
1 shared publication - Magdalena Januszewicz
II Department of Radiology, Medical University of Warsaw, Poland
1 shared publication - Magdalena Marczak
Magnetic Resonance Unit, National Institute of Cardiology, 04-628 Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 29 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5367
Right Ventricular Structure and Function in Patients with Primary Aldosteronism: A Cardiac Magnetic Resonance Study
Background/Objectives: While aldosterone excess has a detrimental impact on the left ventricle, no data exist concerning right ventricular (RV) function in primary aldosteronism (PA) patients. We aimed to assess RV structure and function in patients with PA using cardiac magnetic resonance imaging. Methods: Thirty PA patients and 30 age- and sex-matched healthy volunteers were studied. All patients underwent cardiac magnetic resonance with the assessment of RV structure and function. Results: Neither the RV mass index (RVMi) nor the RV ejection fraction (RVEF) correlated with the aldosterone levels (p = 0.36 and p = 0.37, respectively). On the contrary, we found a weak positive correlation between the RV end-diastolic volume index (RVEDVi) and aldosterone concentration (rho = 0.5, p = 0.005). Neither the RVEDVi nor the RVEF differed between the PA patients and the control group (p = 0.077 and p = 0.93, respectively). The RVMi was higher in the PA group, at 18.9 (4.9) g/m2, versus 13.6 (3.2) g/m2 (SD) in the control group (p < 0.0001). The RVEDVi was positively correlated with the duration of hypertension (rho = 0.4, p = 0.03), and the latter was correlated inversely with the RVEF (rho = −0.47, p = 0.009). The RV global longitudinal strain was impaired in PA patients in comparison with the controls (−16.8 (2.5%) versus −19.6 (2.7%), p = 0.0001). Conclusions: The PA patients exhibited larger RVMi values than the controls. The higher the aldosterone levels were, the higher the observed RVEDVi. Additionally, the longer the duration of hypertension, the higher the observed RVEDVi and the lower the noted RVEF. The PA patients exhibited subclinical RV systolic dysfunction, expressed as impaired RV global longitudinal strain.
- 29 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5367
Open AccessRight Ventricular Structure and Function in Patients with Primary Aldosteronism: A Cardiac Magnetic Resonance Study
Background/Objectives: While aldosterone excess has a detrimental impact on the left ventricle, no data exist concerning right ventricular (RV) function in primary aldosteronism (PA) patients. We aimed to assess RV structure and function in patients with PA using cardiac magnetic resonance imaging. Methods: Thirty PA patients and 30 age- and sex-matched healthy volunteers were studied. All patients underwent cardiac magnetic resonance with the assessment of RV structure and function. Results: Neither the RV mass index (RVMi) nor the RV ejection fraction (RVEF) correlated with the aldosterone levels (p = 0.36 and p = 0.37, respectively). On the contrary, we found a weak positive correlation between the RV end-diastolic volume index (RVEDVi) and aldosterone concentration (rho = 0.5, p = 0.005). Neither the RVEDVi nor the RVEF differed between the PA patients and the control group (p = 0.077 and p = 0.93, respectively). The RVMi was higher in the PA group, at 18.9 (4.9) g/m2, versus 13.6 (3.2) g/m2 (SD) in the control group (p < 0.0001). The RVEDVi was positively correlated with the duration of hypertension (rho = 0.4, p = 0.03), and the latter was correlated inversely with the RVEF (rho = −0.47, p = 0.009). The RV global longitudinal strain was impaired in PA patients in comparison with the controls (−16.8 (2.5%) versus −19.6 (2.7%), p = 0.0001). Conclusions: The PA patients exhibited larger RVMi values than the controls. The higher the aldosterone levels were, the higher the observed RVEDVi. Additionally, the longer the duration of hypertension, the higher the observed RVEDVi and the lower the noted RVEF. The PA patients exhibited subclinical RV systolic dysfunction, expressed as impaired RV global longitudinal strain.